Please assess the completion status of the following clinical trial:

Trial Title: Study of Meloxicam Capsules to Treat Osteoarthritis Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Primary diagnosis of Functional Class I-III OA of the hip or knee~* Chronic user of nonsteroidal anti-inflammatory drugs (NDAIDs) and/or acetaminophen for OA pain~* Discontinued all analgesic therapy at Screening~* For women of child-bearing potential: a woman who is not pregnant and not nursing, and who is practicing an acceptable method of birth control~Exclusion Criteria:~* History of allergic reaction or clinically significant intolerance to acetaminophen, aspirin, or any NSAIDs, including meloxicam~* Requires continuous use of opioid or opioid combination products to control OA pain of the knee or hip~* Clinically significant unstable cardiac, respiratory, neurological, immunological, hematological, or renal disease~* Significant difficulties swallowing capsules or unable to tolerate oral medication~* Previous participation in another clinical study of Meloxicam Capsules or received any investigational drug or device or investigational therapy within 30 days before Screening

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Meloxicam Test Capsules low dose QD (Type: EXPERIMENTAL): Meloxicam Test Capsules low dose QD
- Meloxicam Test Capsules high dose QD (Type: EXPERIMENTAL): Meloxicam Test Capsules high dose QD
- Placebo Capsule QD (Type: PLACEBO_COMPARATOR): Placebo Capsule QD

Based on this trial design, predict the completion outcome and termination type (if applicable).